Floatz logo

Romidepsin

HIV Infection

City of Hope Medical CenterSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

22 Active assets in the HIV Infection cohort.

Asset / SponsorPhaseRating
Lamivudine
José Antonio Mata Marín
Phase 4BBB
ETOPOSIDE
AIDS Malignancy Consortium
Phase 2BBB
Cyclophosphamide
AIDS Malignancy Consortium
Phase 3BB
Metformin
Brigham and Women's Hospital
Phase 4BB
PREDNISONE TABLETS
City of Hope Medical Center
Phase 2BB

View all 50 →

Same molecule, other indications

Romidepsin is also rated in:

Myelodysplastic/Myeloproliferative DiseasesDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Mycosis Fungoides/Sezary SyndromeDormant
BBB
Indicative ·
75 / 100
View asset →
Multiple Myeloma and Plasma Cell NeoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →